FAQs: Luxturna (voretigene neparvovec)
Luxturna, a gene therapy, is only for the treatment of Leber congenital amaurosis type 2 (LCA2) and severe early-onset RP caused by mutations in a specific gene called RPE65.
Search results
Luxturna, a gene therapy, is only for the treatment of Leber congenital amaurosis type 2 (LCA2) and severe early-onset RP caused by mutations in a specific gene called RPE65.
A recording of the Retina UK Professionals' Conference on 23 June 2023. The Conference was held at the University of Westminster, Marylebone Campus in London and online.
We are proud to announce that Amar Latif - adventurer, entrepreneur, TV presenter and public speaker - is to join Retina UK as a volunteer ambassador.
17,000 runners from over 100 countries around the world are expected to take to the roads in March for the 2024 Barcelona Marathon
Superheroes, the race is on and it doesn’t get any bigger than this! As part of #TeamRetinaUK, remotely join forces with hundreds of fellow superheroes around the world!
Bhavini was diagnosed with RP in 1997 aged 17. The consultant who confirmed her diagnosis told her that “there was no cure or treatment and she should prepare to go blind".
Our monthly e-Newsletter featuring the latest updates from Retina UK. Subscribe now to receive these updates directly to your email.
An unmissable event for people of all ages living with varying degrees of sight loss, professionals supporting and advising VIP's and for all businesses and other organisations wishing to improve their services for the visually impaired.
An unmissable event for people of all ages living with varying degrees of sight loss, professionals supporting and advising VIP’s and for all businesses and other organisations wishing to improve their services for the visually impaired.
An unmissable event for people of all ages living with varying degrees of sight loss, professionals supporting and advising VIP’s and for all businesses and other organisations wishing to improve their services for the visually impaired.